Screener
Ginkgo Bioworks DNA Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
| Common stock as of June 30, 2026 | Authorized | Issued | Outstanding |
|---|---|---|---|
| Class A | 10,500,000,000 | 55,202,925 | 52,322,106 |
| Class B | 4,500,000,000 | 8,957,129 | 8,388,996 |
| Class C | 800,000,000 | 3,000,000 | 3,000,000 |
| 15,800,000,000 | 67,160,054 | 63,711,102 | |
| Common stock as of December 31, 2025 | |||
| Class A | 10,500,000,000 | 49,694,610 | 46,791,082 |
| Class B | 4,500,000,000 | 8,985,839 | 8,416,216 |
| Class C | 800,000,000 | 3,000,000 | 3,000,000 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ginkgo Bioworks's common stock?
- Ginkgo Bioworks (DNA) reported common stock of 15.8B in Q2 2026.
- How has Ginkgo Bioworks's common stock changed year-over-year?
- Ginkgo Bioworks's common stock decreased by 0.0% year-over-year, from 15.8B to 15.8B.
- What is the long-term trend for Ginkgo Bioworks's common stock?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's common stock has grown at a 941.4% compound annual growth rate (CAGR), from 129K to 15.8B.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Ginkgo Bioworks's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude